Genetic polymorphisms and the risk of myocardial infarction in patients under 45 years of age

Biochemical Genetics

Volumn 51, Issue 3-4, 2013, Pages 230-242

  Sakowicz, Agata ^a   Fendler, Wojciech ^a   Lelonek, Malgorzata ^a   Sakowicz, Bartosz ^b   Pietrucha, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Atherothrombosis; Coronary artery disease; Myocardial infarction; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; CD31 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; GELATINASE B; GENOMIC DNA; INTERCELLULAR ADHESION MOLECULE 1; INTERSTITIAL COLLAGENASE; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PAI 1 PROTEIN; STROMELYSIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGE FACTORS; ATHEROSCLEROSIS; FEMALE; HETEROZYGOTE DETECTION; HUMANS; HYPERTENSION; MALE; MATRIX METALLOPROTEINASE 3; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING;

EID: 84876693694     PISSN: 00062928     EISSN: 15734927     Source Type: Journal    
DOI: 10.1007/s10528-012-9558-5     Document Type: Article

References (44)

1. Balogh E, Bereczky Z, Katona E, Koszegi Z, Edes I, Muszbek L, Czuriga I (2012) Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study. Thromb Res 129(2):133-138
2. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, Zepponi E, Ursicino N, Chiarotti F, Mariani G (1996) Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 16:72-76
3. Beyzade S, Zhang S, Wong YK, Day IN, Eriksson P, Ye S (2003) Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction. J Am Coll Cardiol 41:2130-2137
4. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579-1585
5. Bozzini C, Girelli D, Bernardi F, Ferraresi P, Olivieri O, Pinotti M, Martinelli N, Manzato F, Friso S, Villa G, Pizzolo F, Beltrame F, Corrocher R (2004) Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis. Thromb Haemost 92:541-549
6. Brown K, Luddington R, Baglin T (1998) Effect of the MTHFRC677T variant on risk of venous thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutations. Br J Haematol 103:32-44
7. Chaer RA, Billeh R, Massad MG (2004) Genetics and gene manipulation therapy of premature coronary artery disease. Cardiology 101:122-130
8. Di Castelnuovo A, D'Orazio A, Amore C, Falanga A, Donati MB, Iacoviello L (2000) The decanucleotide insertion/deletion polymorphism in the promoter region of the coagulation factor VII gene and the risk of familial myocardial infarction. Thromb Res 98:9-17
9. Dikmen M, Ozbabalik D, Gunes HV, Degirmenci I, Bal C, Ozdemir G, Basaran A (2006) Acute stroke in relation to homocysteine and methylenetetrahydrofolate reductase gene polymorphisms. Acta Neurol Scand 113:307-314
10. Doggen CJ, Manger CV, Bertina RM, Reitsma PH, Vandenbroucke JP, Rosendaal FR (1998) A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men. Thromb Haemost 80(2):281-285
11. Doughty M, Mehta R, Bruckman D, Das S, Karavite D, Tsai T, Eagle K (2002) Acute myocardial infarction in the young: the University of Michigan experience. Am Heart J 143:56-62
12. Dunleavey L, Beyzade S, Ye S (2000) Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol 19(2):175-177
13. Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S (2008) The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease. Biochem J 409:349-355
14. Fang L, Wei H, Chowdhury SH, Gong N, Song J, Heng CK, Sethi S, Koh TH, Chatterjee S (2005) Association of Leu125Val polymorphism of platelet endothelial cell adhesion molecule-1 (PECAM-1) gene and soluble level of PECAM-1 with coronary artery disease in Asian Indians. Indian J Med Res 121:92-99
15. Garoufalis S, Kouvaras G, Vitsias G, Perdikouris K, Markatou P, Hatzisavas J, Kassinos N, Karidis K, Foussas S (1998) Comparison of angiographic findings, risk factors, and long term follow-up between young and old patients with a history of myocardial infarction. Int J Cardiol 67:75-80
16. Gnasso A, Motti C, Irace C, Carallo C, Liberatoscioli L, Bernardini S, Massoud R, Mattioli PL, Federici G, Cortese C (2000) Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects. Arterioscler Thromb Vasc Biol 20:1600
17. Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695
18. Heywood DM, Carter AM, Catto AJ, Banford JM, Grant P (1997) Polymorphisms of the factor VII gene and circulating FVII:c levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke 28:816-821
19. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, Tajika T, Murohara T, Yokota M (2003) Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol 42:1429-1437
20. Iqbal MP, Fatima T, Parveen S, Yousuf FA, Shafiq M, Mehboobali N, Khan AH, Azam I, Frossard PM (2005) Lack of association of methylenetetrahydrofolate reductase 677C>T mutation with coronary artery disease in a Pakistani population. J Mol Genet Med 1:26-32
21. Kluijtmans LA, Whitehead AS (2001) Methylenetetrahydrofolate reductase genotypes and predisposition to atherothrombotic disease; evidence that all three MTHFR C677T genotypes confer different levels of risk. Eur Heart J 22:294-299
22. Koenig W, Khuseyinova N (2007) Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 27:15-26
23. Li YY (2012) Methylenetetrahydrofolate reductase C677T gene polymorphism and coronary artery disease in a Chinese Han population: a meta-analysis. Metabolism 61:846-852
24. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874
25. Libby P (2008) The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med 263:517-527
26. Middendorf K, Gohring P, Huehns TY, Seidel D (2004) Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction. Am Heart J 147:897-904
27. Morange PE, Bickel C, Nicaud V, Schnabel R, Rupprecht HJ, Peetz D, Lackner KJ, Cambien F, Blankenberg S, Tiret L (2006) Haemostatic factors and the risk of cardiovascular death in patients with coronary artery disease: the AtheroGene study. Arterioscler Thromb Vasc Biol 26:2793-2799
28. Nederhand RJ, de Maat MP, Jukema JW (2001) Factor VII polymorphisms and myocardial infarction: what is special in Italians? Regression growth evaluation statin study group. Throm Haemost 85:746-747
29. Reny JL, Laurendeau I, Fontana P, Bièche I, Dupont A, Remones V, Emmerich J, Vidaud M, Aiach M, Gaussem P (2004) The TF-603A/G gene promoter polymorphism and circulating monocyte tissue factor gene expression in healthy volunteers. Thromb Haemost 91(2):248-254
30. Rossaak JI, Van Rij AM, Jones GT, Harris EL (2000) Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms. J Vasc Surg 31(5):1026-1032
31. Sakowicz A, Fendler W, Lelonek M, Gluba A, Pietrucha T (2010a) Two polymorphisms of the FVII gene and their impact on the risk of myocardial infarction in Poles under 45 years of age. Mol Biol (Mosk) 44:229-234
32. Sakowicz A, Fendler W, Lelonek M, Pietrucha T (2010b) Genetic variability and the risk of myocardial infarction in Poles under 45 years of age. Arch Med Sci 6:160-167
33. Sasaoka T, Kimura A, Hohta SA, Fukuda N, Kurosawa T, Izumi T (2001) Polymorphisms in the platelet-endothelial cell adhesion molecule-1 (PECAM-1) gene, Asn563Ser and Gly670Arg, associated with myocardial infarction in the Japanese. Ann NY Acad Sci 947:259-269
34. Thim T, Hagensen MK, Bentzon JF, Falk E (2008) From vulnerable plaque to atherothrombosis. J Intern Med 263:506-516
35. Trabetti E, Biscuola M, Cavallari U, Malerba G, Girelli D, Olivieri O, Martinelli N, Corrocher R, Pignatti PF (2006) On the association of the oxidised LDL receptor 1 (OLR1) gene in patients with acute myocardial infarction or coronary artery disease. Eur J Hum Genet 14:127-130
36. Wang J, Xu D, Wu X, Zhou C, Wang H, Guo Y, Cao K (2011) Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis. Heart 97:1542-1546
37. Wenzel K, Stahn R, Speer A, Denner K, Glaser C, Affeldt M, Moobed M, Scheer A, Baumann G, Felix S (1999) Functional characterization of atherosclerosis-associated Ser128Arg and Leu554Phe E-selectin mutations. Biol Chem 380:661-667
38. Xuan C, Bai XY, Gao G, Yang Q, He GW (2011) Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls. Arch Med Res 42(8):677-685
39. Yang Y, Cheng L, Ripen N, He M, Chang Z, Wu T (2007) Association of G+1688A polymorphism of platelet endothelial cell adhesion molecule-1 gene with myocardial infarction in the Chinese Han population. J Huazhong Univ Sci Technol Med Sci 27:520-523
40. Ye S (2006) Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res 69:636-645
41. Ye SQ, Usher D, Virgil D, Zhang LQ, Yochim SE, Gupta R (1999) A PstI polymorphism detects the mutation of serine128 to arginine in CD 62E gene, a risk factor for coronary artery disease. J Biomed Sci 6(1):18-21
42. Yokoyama H, Tahara H, Emoto M, Fujiwara S, Araki T, Shinohara K, Hatsuda S, Maeno T, Shoji T, Koyama H, Shoji T, Nishizawa Y (2005) The K469E polymorphism of the intercellular adhesion molecule-1 gene is associated with plasma fibrinogen level in type 2 diabetes. Metabolism 54(3):381-386
43. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99(14):1788-1794
44. Zhou X, Huang J, Chen J, Su S, Chen R, Gu D (2004) Haplotype analysis of the matrix metalloproteinase 3 gene and myocardial infarction in a Chinese Han population. The Beijing atherosclerosis study. Thromb Haemost 92:867-873